Colonic Adenoma
Conditions
Interventions
Control group:Routine quality control management (Sample size description: The control group consists of endoscopy centres from 6 hospitals, and patients are included continuously within 6 months, wit
Experimental group:Quality control software was used for data feedback (Sample size description: The experimental group consists of endoscopy centres from other 6 hospitals, and patients are included
Sponsors
Wenzhou Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Endoscopy Center Endoscopy centers that have not participated in professional training or clinical trials related to quality control management of digestive endoscopy. All endoscopists performing gastroenteroscopy at the participating centers who meet the inclusion and exclusion criteria are invited to enroll. 2.Endoscopists Endoscopists with more than 1 year of experience. 3.Patients ? Patients aged =18 years; ? Patients requiring diagnostic, screening, or follow-up colonoscopy; ? Patients capable of reading, understanding, and signing the informed consent form; ? Patients who, in the investigator’s opinion, are able to understand the clinical study procedures and are willing and able to cooperate and complete all study procedures.
Exclusion criteria
Exclusion criteria: 1.Endoscopy Center ? Unable to fully receive and implement quality control feedback measures within six months; ? Does not have the routine practice of performing biopsies. 2.Endoscopists Unable to participate in the study throughout its entire duration. 3.Patients ? Already enrolled in other clinical trials, having signed informed consent and still within the follow-up period of those trials; ? Patients whom the investigator deems unsuitable for colonoscopy or related examinations; ? Pregnant or breastfeeding women; ? History of drug or alcohol abuse, or mental illness within the past 5 years; ? Known or suspected multiple polyposis syndrome, inflammatory bowel disease, intestinal obstruction or perforation, bowel strictures, or colorectal tumors; ? History of colorectal surgery; ? Patients with gastrointestinal bleeding; ? History of allergy to antispasmodics or bowel-cleansing agents previously used; ? Unable to undergo biopsy or polypectomy due to coagulation disorders or use of anticoagulants; ? Premature termination of colonoscopy due to rapid changes in heart or respiratory rate, patient intolerance, obstruction, large space-occupying lesions, poor bowel preparation, or failure to reach the cecum.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adenoma detection rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Polyp detection rate;Adenoma detection rates by size and location;Polyp detection rates by size and location;Colonoscopy time;Cecal intubation rate;Adverse reaction; | — |
Countries
China
Contacts
Public ContactJie Pan
Wenzhou Central Hospital
Outcome results
None listed